NEW YORK, NY / ACCESS Newswire / November 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Varonis Systems, Inc. ("Varonis Systems, Inc.") (NASDAQ:VRNS) concerning possible violations of federal securities laws. On October 28, 2025, Varonis reported third quarter fiscal 2025 revenue below estimates on the back of weaker […]
NEW YORK, NY / ACCESS Newswire / November 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Molina Healthcare, Inc. ("Molina Healthcare, Inc.") (NYSE:MOH) concerning possible violations of federal securities laws. On October 23, 2025, Molina published its third quarter, fiscal 2025 earnings well below consensus and slashed its
We are advised by Aventiv Technologies that journalists and other readers should disregard the news release, Aventiv Technologies Sponsors Mission: Launch Los Angeles Hackathon Event to Expand Workforce Opportunity Through Innovation, issued 05-Nov-2025 over PR Newswire. SOURCE Aventiv Technologies https://rt.newswire.ca/rt.gif?NewsItemId=PH15898&Transmission_Id=202511071032PR_NEWS_USPR_____PH15898A&DateId=20251107
NEW YORK, NY / ACCESS Newswire / November 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of F5, Inc. ("F5, Inc.") (NASDAQ:FFIV) concerning possible violations of federal securities laws. F5 disclosed on October 15, 2025, that the company learned on August 9, 2025 "that a highly sophisticated nation-state threat
As the holiday season approaches, one essential product that continues to improve lives is the oxygen concentrator. For individuals living with chronic respiratory conditions, having reliable access to supplemental oxygen can make a world of difference-enhancing comfort, mobility, and confidence in daily life. https://mma.prnewswire.com/media/2660036/varon_oxygen_concentrator_logo_Logo.jpg Just ahead of Black Friday, VARON, a trusted provider of portable
(NASDAQ:CYTK), LOS ANGELES, Nov. 07, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against Cytokinetics, Incorporated (“Cytokinetics” or “the Company”) (NASDAQ: CYTK) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders
Cytokinetics, Incorporated Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – CYTK GlobeNewswire November 07, 2025 LOS ANGELES, Nov. 07, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against Cytokinetics, Incorporated (“Cytokinetics” or “the Company”) (NASDAQ: CYTK) for violations of §§10(b)
“As a Biology educator with aPh.D., I wanted to create a digital display board solution that would allow teachers to display and efficiently maintain their daily instructional plan information per school district best practices,” said an inventor, from Tucker, Ga., “so I invented the DEDICATED DAILY INSTRUCTIONAL BOARD FOR EDUCATORS. My design offers a time-saving
The global Preimplantation Genetic Testing Market, valued at US$636.4 million in 2024, stood at US$690.2 million in 2025 and is projected to advance at a resilientCAGR of 10.5% from 2025 to 2030, culminating in a forecasted valuation of US$1,135.0 million by the end of the period. The market is driven by the rising prevalence of
Independent Advisor Solutions (“iAS”) is excited to announce the launch of Global Equity Market Neutral (“GEMN”, pronounced “Gem”), the latest addition to its acclaimed MiBLOX suite. This launch marks a significant expansion of iAS's strategic partnership with Goldman Sachs Asset Management (“GSAM”), offering Canadian investors exclusive access to a sophisticated, globally diversified, market-neutral investment strategy.